Showing results (411-420 of 430) with videos related to
Sort By:
Pageof 43
Alimentary Pharmacology & Therapeutics|June 6, 2003
A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese populationW M Wong, K F Lam, K C Lai, et al.Antimicrobial Agents and Chemotherapy|December 30, 2016
In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and AnidulafunginSusanna K P Lau, George C S Lo, Clare S K Lam, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 11, 2002
Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in ChineseW H C Hu, N Y H Wong, K C Lai, et al.Alimentary Pharmacology & Therapeutics|February 12, 2004
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux diseaseW M Wong, K C Lai, W M Hui, et al.Journal of Gastroenterology and Hepatology|December 3, 1998
Differential north to south gastric cancer-duodenal ulcer gradient in China. China Ulcer Study GroupB C Wong, C K Ching, S K Lam, et al.Alimentary Pharmacology & Therapeutics|November 18, 2003
A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese populationB C-Y Wong, W M Wong, K L Cheung, et al.Alimentary Pharmacology & Therapeutics|November 1, 2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled studyB C Wong, W H Wang, W M Wong, et al.Journal of Gastroenterology and Hepatology|February 24, 1999
Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study GroupB C Wong, S K Lam, C K Ching, et al.Alimentary Pharmacology & Therapeutics|December 12, 2001
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionB C Wong, W M Wong, Y K Yee, et al.Alimentary Pharmacology & Therapeutics|January 29, 2000
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled studyB C Wong, S D Xiao, F L Hu, et al.Pageof 43